Improving the Prognostic Ability for Personalized Therapeutic Approaches in Nonseminomatous Germ Cell Tumors

被引：3
|
作者：
Necchi, Andrea [1 ]
Ross, Jeffrey S. [2 ,3 ]
Spiess, Philippe E. [4 ]
机构：
[1] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Milan, Italy
[2] Upstate Med Univ, Syracuse, NY USA
[3] Fdn Med, Cambridge, MA USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 26期
关键词：
INTERMEDIATE; TERATOMA;
D O I：
10.1200/JCO.19.01672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2314 / +
页数：4
相关论文
共 50 条
  • [41] Prognostic factors in the management of clinical stage I (CS I) nonseminomatous germ cell tumors of the testis (NSGCTT)
    Ondrus, D
    Bujdak, P
    Dubravicky, J
    Dzurny, O
    Goncalves, F
    Miklosi, M
    Sablova, D
    Stefancik, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 184 - 184
  • [42] NONSEMINOMATOUS GERM-CELL TUMORS - ENLARGING MASSES DESPITE CHEMOTHERAPY
    PANICEK, DM
    TONER, GC
    HEELAN, RT
    BOSL, GJ
    RADIOLOGY, 1990, 175 (02) : 499 - 502
  • [43] Frequent inactivation of the pAkt pathway genes in nonseminomatous germ cell tumors
    Merseburger, A. S.
    Hennenlotter, J.
    Vogel, U.
    Springer, C.
    Anastasiadis, A. G.
    Hartmann, J. T.
    Stenzl, A.
    Kuczyk, M. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 156 - 156
  • [44] Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors
    Hartmann, JT
    Nichols, CR
    Droz, JP
    Horwich, A
    Gerl, A
    Fossa, SD
    Beyer, J
    Pont, J
    Fizazi, K
    Einhorn, L
    Kanz, L
    Bokemeyer, C
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (01): : 54 - 61
  • [45] NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - CURRENT CONCEPTS AND CONTROVERSIES
    SHEINFELD, J
    UROLOGY, 1994, 44 (01) : 2 - 14
  • [46] Clinical and radiographic characterization of primary seminomas and nonseminomatous germ cell tumors
    Gu, L.
    Zhang, L.
    Hou, N.
    Li, M.
    Shen, W.
    Xie, X.
    Teng, Y.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2019, 22 (03) : 342 - 349
  • [47] Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors
    Bokemeyer, C
    ONCOLOGY, 1998, 55 (03) : 177 - 188
  • [48] Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors
    Netto, Georges J.
    Nakai, Yasutomo
    Nakayama, Masashi
    Jadallah, Sana
    Toubaji, Antoun
    Nonomura, Norio
    Albadine, Roula
    Hicks, Jessica L.
    Epstein, Jonathan I.
    Yegnasubramanian, Srinivasan
    Nelson, William G.
    De Marzo, Angelo M.
    MODERN PATHOLOGY, 2008, 21 (11) : 1337 - 1344
  • [49] Management of residual mass in nonseminomatous germ cell tumors following chemotherapy
    Daneshmand, Siamak
    Djaladat, Hooman
    Nichols, Craig
    THERAPEUTIC ADVANCES IN UROLOGY, 2011, 3 (04) : 163 - 171
  • [50] CYTOREDUCTIVE SURGERY FOR ADVANCED NONSEMINOMATOUS GERM-CELL TUMORS OF TESTIS
    BRENNER, J
    VUGRIN, D
    WHITMORE, WF
    UROLOGY, 1982, 19 (06) : 571 - 575
12345